Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer (MIcRobiome Analysis in Patients UnderGoing PancrEatico-duodenectomy for Pancreatic Cancer MIRAGE Study)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
30 participants
Jul 11, 2022
INTERVENTIONAL
Conditions
Summary
Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.
Eligibility
Inclusion Criteria4
- Age ≥18 years
- Diagnosis of resectable pancreatic adenocarcinoma with indication for "upfront" surgical treatment
- ASA (American Society of Anesthesiology) score \< 4
- Obtaining informed consent
Exclusion Criteria1
- \- Pregnant or lactating women
Interventions
Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06800469